Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
Open Access
- 1 January 2023
- journal article
- research article
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 18 (1) , 20220652
Abstract
The aim of this study is to investigate certain genetic features of intrahepatic cholangiocarcinoma (ICCA). A total of 12 eligible ICCA patients were enrolled, and tumor tissues from the patients were subjected to next-generation sequencing of a multi-genes panel. Tumor mutation burden (TMB), mutated genes, copy number variants (CNVs), and pathway enrichment analysis were performed. The median TMB was 2.76 Mutation/Mb (range, 0–36.62 Mutation/Mb) in ICCA patients. The top two most commonly mutated genes in ICCA were KRAS (33%) and TP53 (25%). The co-mutations of KRAS and TP53 were 16.7% (2/12) in ICCA patients. Notably, patient P6 with the highest TMB did not have KRAS and TP53 mutations. Additionally, TP53 and/or KRAS alterations were significantly associated with poor progression-free survival than those with wild type (1.4 months vs 18 months). DNA damage repair and homologs recombinant repair deficiencies were significantly associated with high TMB in ICCA cases. In conclusion, we found that certain genetic mutations of TP53 and KRAS could predict poor prognosis in ICCA patients.Keywords
This publication has 55 references indexed in Scilit:
- Alterations in DNA Damage Repair Genes in Primary Liver CancerClinical Cancer Research, 2019
- Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived CholangiocarcinomaCancer Research, 2018
- Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registriesThe Lancet Global Health, 2018
- Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutationsJournal of Hepatology, 2018
- Prognostic significance of copy number alterations detected by multi‑link probe amplification of multiple genes in adult acute lymphoblastic leukemiaOncology Letters, 2018
- Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue SarcomasCell, 2017
- AACR Project GENIE: Powering Precision Medicine through an International ConsortiumCancer Discovery, 2017
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenGenome Medicine, 2017
- FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolutionBioinformatics, 2014
- B lymphoblastic leukemia with ETV6 amplificationCancer Genetics and Cytogenetics, 2010